Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
29.43
+0.50 (1.73%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Maze Therapeutics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Maze Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $62.55. The average 1-year stock price forecast is 112.54% higher than the current stock price, while the lowest is $46 (+56.30%) and the highest is $110 (+273.77%).
Price Target: $62.55 (+112.54%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $64 | Buy | Maintains | $64 | +117.47% | Aug 13, 2026 |
| Wedbush | Wedbush | Buy Maintains $48 | Buy | Maintains | $48 | +63.10% | Aug 12, 2026 |
| BTIG | BTIG | Buy Maintains $46 | Buy | Maintains | $46 | +56.30% | Aug 12, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $55 | Buy | Reiterates | $55 | +86.88% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $110 | Buy | Maintains | $110 | +273.77% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
20.00M
Revenue Next Year
9.73M
from 20.00M
Decreased by -51.35%
EPS This Year
-2.73
from -3.05
EPS Next Year
-3.18
from -2.73
EPS and Forward PE are based on non-GAAP adjusted numbers.